Nouvelle publication pour l’équipe EpiDermE de la FHU TRUE : […] Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study Lire la suite »
